After completing his internship at the Sphera investment fund, Mr. Itai Arkin joined Arkin Holdings in 2014 as a dermatology and investments research analyst. He serves on the board of directors at Exalenz Bioscience, Kamari Pharma, and Sol-Gel, and is a member of both Accelmed and Sphera Global Healthcare’s investment committees.

Mr. Arkin holds an MBA cum laude with a major in accounting and finance from Tel Aviv Univresity, and a BA cum laude in business administration from the Interdisciplinary Center, Herzliya.